跳至主要内容
临床试验/ACTRN12612000795897
ACTRN12612000795897已完成4 期

A randomized controlled trial comparing the effectiveness of intranasal ketamine and fentanyl in the relief of moderate to severe pain in children with limb injuries.

Southern Health0 个研究点目标入组 80 人开始时间: 2012年7月27日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
3 Years 至 13 Years(—)
性别
All

入选标准

  • Children aged three to 13 years and under 50kg body weight
  • Musculoskeletal injury to upper and/or lower limbs
  • Visual analogue pain score greater than or equal to 6/10 on the standard 11-point verbal rating scale (0 = none, 10 = worst pain imaginable) and patient would normally be considered for intranasal fentanyl administration.
  • Use of simple analgesia such as paracetamol or ibuprofen or inhalational methoxyflurane during ambulance transport are not exclusion criteria

排除标准

  • Inability to gain informed consent from parent or guardian
  • Prior administration of parenteral or intranasal analgesics (morphine, fentanyl)
  • Prior administration of oral opioid analgesia (oxycodone, codeine)
  • Allergy to ketamine, fentanyl, or ibuprofen
  • Aberrant nasal anatomy
  • Acute or chronic nasal problems or nasal trauma that may preclude adequate administration or absorption of intranasal medication.
  • Presence of multiple trauma or injuries.
  • Sustained a head injury with loss of consciousness.
  • Presence of cognitive impairment.

研究者

发起方
Southern Health

相似试验